Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

NACompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Type2 Diabetes
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

Subjects will use a CGM to develop an understanding of how their behaviors influence their glucose levels.

DEVICE

Activity Tracker

Subjects will use the activity tracker, in combination with a continuous glucose monitor (CGM), to develop an understanding of how their activity levels affect their glucose levels.

BEHAVIORAL

Coaching

Coaches will help subjects understand the readings from the CGMs and how they are affected by diet choices, use of diabetes medications, etc. Coaches and subjects will have weekly conversations about CGM data and behaviors that affect CGM readings. Coaching will occur via telephone, text messaging, and automated text messaging.

Trial Locations (1)

89102

Southwest Medical Associates, Las Vegas

All Listed Sponsors
lead

Savvysherpa, Inc.

INDUSTRY

NCT03290768 - Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) | Biotech Hunter | Biotech Hunter